Historical review from 2026-10-01. Current price and availability are unconfirmed; check the original marketplace.
Scantrader demonstrates exceptional unit economics: $13.8K monthly revenue with 85% profit margins yields $11.7K/mo profit at a lean 2.5x multiple. Platform verification and four months of operating history support the credibility of the financials. However, the extremely brief business description and early-stage age (4 months) create material uncertainty around customer durability, churn, and the sustainability of the current margin profile—details a buyer must confirm independently before proceeding.
Building a fintech trading-analysis tool with similar scope (data integration, charting, analytics, AI model inference) would cost $8K–$15K in AI-assisted development (Claude Pro + LLM API subscriptions, open-source charting libraries, managed databases, third-party market data APIs) and require 8 weeks for a solo founder. However, the acquisition wins decisively on two fronts: (1) Scantrader has already acquired paying customers and achieved verified $11.7K/mo recurring profit over four months—that traction and distribution cannot be replicated quickly; (2) the fintech domain carries regulatory and trust-building complexity that purchasing an established product compresses to days rather than months. The low build cost reflects commoditization of the software layer; the real value lies in proven unit economics and customer relationships. Buy at 2.5x multiple to capture four months of validated traction and market fit immediately.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Highly profitable AI-powered fintech software for trading analysis.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.